financetom
Business
financetom
/
Business
/
Amgen's experimental skin disease drug meets main goals in study
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Amgen's experimental skin disease drug meets main goals in study
Sep 26, 2024 10:01 AM

Sept 24 (Reuters) - Amgen ( AMGN ) said on Tuesday its

experimental drug, rocatinlimab, met the main goals in a late

stage study testing it as a treatment for an inflammatory skin

condition known as atopic dermatitis.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
MercadoLibre's fourth-quarter net profit beats forecast, shares jump
MercadoLibre's fourth-quarter net profit beats forecast, shares jump
Feb 20, 2025
SAO PAULO (Reuters) -Latin American e-commerce giant MercadoLibre posted a better-than-expected quarterly net profit on Thursday, up nearly four-fold from the same period a year earlier and sending its shares up more than 12% in after-hours trading. MercadoLibre, Latin America's largest company by market value, said net income for the October-to-December quarter came in at $639 million, up 287% year-on-year...
DOGE cuts nearly half of unit overseeing autonomous vehicles safety, Washington Post reports
DOGE cuts nearly half of unit overseeing autonomous vehicles safety, Washington Post reports
Feb 20, 2025
Feb 20 (Reuters) - Elon Musk-led Department of Government Efficiency has cut three out of roughly seven people in a U.S. auto safety agency unit overseeing the safety of autonomous vehicles, the Washington Post reported on Thursday. The workers fired by the agency headed by the Tesla CEO said they do not believe they were targeted because they are examining...
L3Harris pushes ahead on Arkansas rocket motor factories
L3Harris pushes ahead on Arkansas rocket motor factories
Feb 20, 2025
Feb 20 (Reuters) - L3Harris Technologies ( LHX ) said on Thursday it has begun constructing four solid rocket motor production facilities at its Camden, New Jersey, site, as demand for missiles accelerates amid escalating geopolitical tensions. The expansion, part of a $215.6 million agreement under the Pentagon's Defense Production Act program, aims to increase domestic manufacturing capacity through the...
Huawei founder told Xi China's concerns about lack of chips have eased, state media says
Huawei founder told Xi China's concerns about lack of chips have eased, state media says
Feb 20, 2025
SHANGHAI (Reuters) - Huawei's founder told Xi Jinping at a meeting the Chinese president held with private sector entrepreneurs that concerns China had about a lack of homegrown chips or operating systems had eased, Chinese state media reported. The People's Daily on Friday published an article summarising what major Chinese company founders including Huawei's Ren Zhengfei, electric vehicle giant BYD's...
Copyright 2023-2026 - www.financetom.com All Rights Reserved